Le Lézard
Classified in: Ebola virus, Health, Science and technology
Subject: PER

Groundbreaking Global Initiative on Sharing All Influenza Data (GISAID) Celebrates Tenth Anniversary


GENEVA, May 21, 2018 /CNW/ -- Noted among the key organizations contributing to global health security for its data-sharing program used to combat Influenza, the Global Initiative on Sharing All Influenza Data (GISAID) is celebrating a decade of enabling near real-time surveillance to respond to and mitigate seasonal and pandemic influenza. Initiated in 2008, it has been called "one the most successful global collaborations ever achieved" by luminaries such as Dr Robert Webster, the foremost expert on bird flu.

To mark the occasion, global public health experts and leading researchers emphasized the contributions of GISAID, while government officials from countries such as China, Indonesia and Brazil will recognize its importance at the 2018 World Health Assembly in Geneva, Switzerland this week.

Comprised of more than 8,000 scientists and over 1,000 institutions worldwide, GISAID's unique, sharing mechanism allows public health officials, scientists and industry to determine how the viruses have mutated and what specific interventions are needed. For example, in 2013 when a new, lethal avian flu strain appeared in China, its authorities relied on GISAID to share genetic data of the virus, receiving accolades for its well-handled response to the outbreak.

"The tenth anniversary of GISAID represents a landmark in global solidarity," said Prof. Lawrence O. Gostin of the World Health Organization (WHO) Collaborating Center on National and Global Health Law at Georgetown University.  "A pandemic strain of influenza is perhaps the world's greatest threat. Everything GISAID stands for: virus sharing, cutting-edge research, open access and international cooperation to guarantee health security couldn't be more important."

Today, GISAID also announced the addition of two important experts joining organization in senior advisory roles. Former Assistant Director General of WHO Dr Marie-Paule Kieny and former U.S. State Department and Department of Defense official, Dr Bruce A. Ruscio.  Kieny will advise GISAID on international affairs and Ruscio on data and biosecurity issues. 

"In a world where global emerging disease threats demand effective sharing of information, GISAID has demonstrated what can be achieved by galvanizing the interests of public health officials, academia and industry to combat influenza, said Kieny."

GISAID's positive impact also shines a light on the challenges still being faced when it comes to sharing critical data of non-influenza pathogens.  Both scientists and governments have repeatedly pointed to GISAID as a model that could be adapted for other dangerous viruses such as Ebola, Zika and Middle East Respiratory Syndrome (MERS).

GISAID was formed when the paths of the then US Secretary of Homeland Security, Michael Chertoff, and a former senior studio executive at Time Warner, Peter Bogner, crossed paths at the 2006 World Economic Forum. Bogner then met and heard the impassioned plea of a top CDC official, Dr Nancy Cox, articulating the threat of the deadly bird flu and the vision for GISAID was established. 

"GISAID's success exceeded our expectations and provides an important model for rapid data sharing for other pathogens with pandemic potential," said Dr Cox. "It's a global health imperative that we look for more ways to collaborate."

To learn more about GISAID's history, mission, research and goals, please visit www.GISAID.org.

About GISAID
The GISAID Initiative promotes the international sharing of all influenza virus sequences, related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses, to help researchers understand how the viruses evolve, spread and potentially become pandemic.

Press Contact:

Todd Ringler


Edelman                     


617.872.1235

 

SOURCE GISAID


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: